Spit test ‘better than blood test for men with genetic prostate cancer risk’

A prostate cancer spit test is better for men with higher genetic risk than a standard blood test, research suggests (David Davies/PA)

At-home spit tests are better than the standard blood test for identifying men who have a high genetic risk of developing aggressive prostate cancer, early research suggests.

The preliminary findings, presented at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago, raise hopes of a potentially more accurate screening tool.